cons of glp 1 shots Brain scientists are seeking weight-loss drugs without the nausea : GLP-1s: What They Are and

Waiting times vary by region

It's an educational estimation tool, not a clinical diagnostic

In that environment of uncertainty comes a new study published last Thursday in JAMA Ophthalmology demonstrating that more than twice as many patients with diabetes exposed to GLP-1 agonists developed neovascular age-related macular degeneration (wet AMD) compared with those in a matched cohort of similar patients who were unexposed

This finding was not seen in people who used GLP-1 medications for shorter periods and has not been consistently confirmed across other studies

GLP-1 meds, decoded: weekly vs daily options and how they differ for appetite, glucose, and weight

All weight loss medication decisions should be made in consultation with a licensed healthcare professional who can evaluate medical history, potential risks, contraindications, and overall suitability